News
Efferon updates: key clinical results, regulatory milestones, and global market expansion
- 24 June 2026Efferon on ESPNIC 2026
- 22 April 2026Efferon®NEO Receives CE MDR Mark
- 10 April 2026Efferon at ISICEM
- 08 April 2026Efferon first distributors meeting
- 11 March 2026Efferon is now available in Poland
- 26 February 2026Efferon®LPS is available in Costa Rica
- 18 February 2026Efferon®LPS is now approved in Thailand
- 10 December 2025Efferon LPS® incorporated into clinical guidelines of the German Society of Nephrology for therapeutic apheresis
- 25 November 2025We’ll see each other in Greece
- 05 November 2025Efferon therapies are now available in Armenia!
- 30 October 2025Clinical data confirmed the effectiveness of Efferon NEO in children with sepsis
- 18 October 2025Efferon LPS has been approved in the Kingdom of Saudi Arabia.
- 09 October 2025Extracorporeal removal of antibiotic drugs during Efferon LPS hemoadsorption is predictable and manageable
- 05 October 2025Efferon at the 6th Asia Pacific AKI CRRT Congress in Bangkok
- 12 September 2025Win a New iPad! Join the Efferon LPS Photo Challenge on LinkedIn
- 23 July 2025Efferon LPS hemoadsorption device has been granted regulatory approval in the United Kingdom and Croatia.
- 01 July 2025Efferon LPS Now Available in Italy
- 28 June 2025Applying Vicenza’s Lessons
- 23 June 2025Efferon Expands Its Global Presence
- 06 June 2025Efferon expands to new markets with Bertossi partnership
- 25 May 2025Efferon LPS becomes available in Romania.
- 22 July 2024New distribution agreements in European countries
- 29 April 2024Efferon LPS receives CE mark under EU MDR
- 20 April 2023Results of LASSO mRCT are published in Shock
- 03 November 2022Efferon at LIVES 2022 in Paris
- 30 November 2021Efferon has participated in MEDICA
- 29 April 2021LASSO multicenter randomized trial launched